INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
INVO Fertility (NASDAQ: IVF), a healthcare services company focused on expanding access to advanced fertility treatments, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025. The company will engage in a virtual webcast fireside chat at 4:15 p.m. ET and conduct one-on-one meetings with investors throughout the event.
The webcast will be accessible through the conference homepage and will be available for replay after the event. Investors interested in one-on-one meetings with management can arrange them through Lytham Partners or by registering for the event directly on their website.
INVO Fertility (NASDAQ: IVF), un'azienda di servizi sanitari specializzata nell'ampliare l'accesso a trattamenti di fertilità avanzati, ha annunciato la sua partecipazione alla Lytham Partners Spring 2025 Investor Conference che si terrà il 29 maggio 2025. L'azienda parteciperà a una discussione virtuale in formato fireside chat alle 16:15 ET e terrà incontri individuali con gli investitori durante l'evento.
La trasmissione sarà disponibile tramite la homepage della conferenza e potrà essere rivista anche dopo l'evento. Gli investitori interessati a incontri individuali con il management possono organizzarli tramite Lytham Partners o registrandosi direttamente sul sito web dell'evento.
INVO Fertility (NASDAQ: IVF), una empresa de servicios de salud enfocada en ampliar el acceso a tratamientos avanzados de fertilidad, ha anunciado su participación en la próxima Conferencia de Inversores Lytham Partners Spring 2025 el 29 de mayo de 2025. La compañía participará en una charla virtual tipo fireside chat a las 4:15 p.m. ET y realizará reuniones individuales con inversores durante todo el evento.
La transmisión estará disponible a través de la página principal de la conferencia y podrá verse en repetición después del evento. Los inversores interesados en reuniones individuales con la dirección pueden organizarlas a través de Lytham Partners o registrándose directamente en el sitio web del evento.
INVO Fertility (NASDAQ: IVF)는 첨단 생식 치료 접근성을 확대하는 데 주력하는 의료 서비스 회사로, 2025년 5월 29일에 개최되는 Lytham Partners Spring 2025 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 동부 표준시 오후 4시 15분에 가상 웨비스트 파이어사이드 채팅에 참여하며, 행사 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다.
웨비스트는 컨퍼런스 홈페이지를 통해 접속 가능하며, 행사 후에도 다시보기로 제공됩니다. 경영진과의 일대일 미팅을 원하는 투자자는 Lytham Partners를 통해 또는 행사 웹사이트에서 직접 등록하여 예약할 수 있습니다.
INVO Fertility (NASDAQ : IVF), une entreprise de services de santé spécialisée dans l'élargissement de l'accès aux traitements de fertilité avancés, a annoncé sa participation à la conférence des investisseurs Lytham Partners Spring 2025 qui aura lieu le 29 mai 2025. La société participera à une discussion virtuelle de type fireside chat à 16h15 ET et organisera des réunions individuelles avec les investisseurs tout au long de l'événement.
Le webinaire sera accessible via la page d'accueil de la conférence et pourra être visionné en replay après l'événement. Les investisseurs souhaitant organiser des réunions individuelles avec la direction peuvent le faire via Lytham Partners ou en s'inscrivant directement sur le site de l'événement.
INVO Fertility (NASDAQ: IVF), ein Gesundheitsdienstleistungsunternehmen, das sich auf die Erweiterung des Zugangs zu fortschrittlichen Fruchtbarkeitsbehandlungen spezialisiert hat, hat seine Teilnahme an der bevorstehenden Lytham Partners Spring 2025 Investor Conference am 29. Mai 2025 angekündigt. Das Unternehmen wird an einem virtuellen Fireside-Chat um 16:15 Uhr ET teilnehmen und während der Veranstaltung Einzelgespräche mit Investoren führen.
Der Webcast ist über die Startseite der Konferenz zugänglich und wird nach der Veranstaltung als Aufzeichnung verfügbar sein. Investoren, die Einzelgespräche mit dem Management wünschen, können diese über Lytham Partners oder durch direkte Anmeldung auf der Veranstaltungswebseite arrangieren.
- None.
- None.
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, will participate in a webcast fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025.
Company Webcast
The webcast presentation will take place at 4:15 p.m. ET on Thursday, May 29, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2025/ or directly at https://app.webinar.net/AlmOGnMNXag. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2025invreg/.
About INVO Fertility
We are a healthcare services fertility company dedicated to expanding assisted reproductive technology (”ART”) care to patients in need. Our principal commercial strategy is focused on building, acquiring and operating fertility clinics, including “INVO Centers” dedicated primarily to offering the intravaginal culture (“IVC”) procedure enabled by our INVOcell® medical device (“INVOcell”) and US-based, profitable in vitro fertilization (“IVF”) clinics. We have two operational INVO Centers in the United States and one IVF clinic. We also continue to engage in the sale and distribution of our INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more natural, intimate, and affordable experience in comparison to other ART treatments. We believe the IVC procedure can deliver comparable results at a fraction of the cost of traditional IVF and is a significantly more effective treatment than intrauterine insemination (“IUI”). For more information, please visit www.invofertility.com.
For more information, please contact:
INVO Fertility, Inc.
Steve Shum, CEO
978-878-9505
sshum@invobio.com
Investor Contact
Lytham Partners, LLC
Robert Blum
602-889-9700
INVO@lythampartners.com
FAQ
When is INVO Fertility (IVF) presenting at the Lytham Partners Spring 2025 Conference?
How can investors access INVO Fertility's (IVF) webcast presentation?
How can investors schedule one-on-one meetings with INVO Fertility (IVF) management?
What is INVO Fertility's (IVF) main business focus?
